Rossari Biotech Stock Prediction 2026: Expert Analysis, Forecast Scenarios and Full Stock Review
- June 16, 2026
- Posted by: Kunal Singla
- Category: News
Rossari Biotech (NSE:ROSSARI) CMP: Rs 515.35 (2026). 52W High: Rs 768. 52W Low: Rs 373. MCap: Rs 2,853 Cr. P/E: 20.0. Sector: Specialty Chemicals and Agrochemicals. JM Financial: Neutral Rs 620. Ko…
The Rossari Biotech stock prediction for 2026 from leading brokerages covers a range reflecting sector dynamics, earnings trajectory and the macro environment. All estimates may or may not be achieved. Treat any Rossari Biotech share price prediction as one data point and not as a guarantee of future performance.
This article reviews every dimension of the Rossari Biotech stock forecast analysts are tracking, including key drivers, bull and bear scenarios and the primary risks. Verify all figures with the latest brokerage reports before any investment decision.
Click Here – Get Free Investment Predictions
What Analysts Predict for Rossari Biotech Stock in 2026
Analyst consensus on the Rossari Biotech stock prediction for 2026 is tracked by leading brokerages. The table below shows the latest available data from JM Financial and Kotak Securities. All figures are sourced from publicly available research and should be verified before publishing.
| Brokerage | Rating | Rossari Biotech Stock Prediction (Rs) | Updated |
|---|---|---|---|
| JM Financial | Neutral | Rs 620 | 2026 |
| Kotak Securities | Neutral | Rs 580 | 2026 |
| Analyst Consensus | — | Rs 600 | 2026 |
The analyst target range for Rossari Biotech reflects genuine difference of opinion on demand recovery, margin trajectory and sector headwinds. The implied upside in the Rossari Biotech stock forecast from the current price of Rs 515.35 may or may not be realised by end of 2026.
3 Stocks Building Serious Momentum Right Now
When Univest analysts identify high-conviction stock opportunities, investors pay attention.
Our research team has shortlisted the Top Stocks to Buy based on current market momentum, sector trends & growth potential for 2026.
- Discover stocks investors are actively accumulating
- High-conviction opportunities backed by research
- Designed for the next phase of market growth
Unlock the latest Top Stock Picks now on Univest
Rossari Biotech Company Overview
Rossari Biotech is a specialty chemicals or agrochemical company serving domestic and global markets. The Rossari Biotech stock prediction for 2026 reflects export recovery potential and margin expansion from operating leverage.
| Metric | Value |
|---|---|
| NSE Ticker | ROSSARI |
| Sector | Specialty Chemicals and Agrochemicals |
| CMP | Rs 515.35 (2026) |
| 52 Week High | Rs 768 |
| 52 Week Low | Rs 373 |
| Market Cap | Rs 2,853 Cr |
| P/E Ratio | 20.0 |
| Rossari Biotech Stock Prediction Consensus (12M) | Rs 600 |
Rossari Biotech Stock Prediction by Time Horizon
Analysts split the Rossari Biotech share price prediction across time frames as near-term drivers differ materially from the long-term view.
Short-Term Rossari Biotech Stock Prediction
The near-term Rossari Biotech stock forecast reflects current sentiment, sector news and upcoming earnings prints. Key support and resistance levels around Rs 515.35 are being watched closely. A short-term Rossari Biotech share price prediction carries the most uncertainty of any time horizon.
12-Month Rossari Biotech Stock Prediction
JM Financial targets Rs 620 (Neutral) and Kotak Securities targets Rs 580 (Neutral). Most desks refresh their Rossari Biotech stock forecast within two to four weeks of each quarterly earnings print. The Rossari Biotech share price prediction should be verified against the most recent analyst reports.
Long-Term Rossari Biotech Stock Prediction
The long-term outlook for Rossari Biotech is built on assumptions about demand recovery, margin expansion and revenue diversification in the Specialty Chemicals and Agrochemicals sector. Long-term price targets carry the most uncertainty and should be treated as directional guidance only.
Rossari Biotech Stock Forecast: Key Factors
The following four factors appear consistently in analyst research on Rossari Biotech and are the primary inputs into the bull and bear case scenarios.
Export Revenue Recovery
A recovery in global chemical demand is the primary catalyst in the Rossari Biotech stock forecast. Analysts who set a higher Rossari Biotech stock prediction point to export order recovery as their main justification for the Rossari Biotech share price prediction.
Capacity Utilisation and Operating Leverage
Rising capacity utilisation from recent capital investment drives operating leverage and margin expansion. Analysts revise the Rossari Biotech share price prediction upward when utilisation improves.
Product Mix and Value Addition
A shift toward higher-value specialty products improves realization. Analysts track the specialty-to-commodity revenue ratio in their Rossari Biotech share price prediction models.
EBITDA Margin Trajectory
Sustained EBITDA margin is typically the basis for the bullish Rossari Biotech stock prediction. Margin recovery is the single most important variable in the Rossari Biotech stock forecast from most research desks.
Rossari Biotech Stock Prediction: Bull and Bear Scenarios
| Scenario | Rossari Biotech Stock Prediction | Key Conditions |
|---|---|---|
| Bull Case | Rs 620 | Strong execution, margin improvement, favourable macro and sector re-rating |
| Base Case | Rs 600 | Steady performance, gradual recovery, margins hold, growth on track |
| Bear Case | Rs 373 | Demand deterioration, margin pressure, sector de-rating and macro headwinds |
The bull case Rossari Biotech stock forecast of Rs 620 assumes most positive variables converge. The base case of Rs 600 is the analyst consensus and may or may not be achieved.
How Analysts Are Reading the Rossari Biotech Stock Story
Analyst reviews of the Rossari Biotech share price prediction highlight the company’s core strengths in Specialty Chemicals and Agrochemicals alongside near-term headwinds from macro uncertainty, competitive pressure and sector-level challenges. Overall the analyst consensus for Rossari Biotech is built on real business strengths set against real risks.
Key Risks to the Rossari Biotech Stock Prediction
China Competition
Chinese producers compete aggressively on price. Dumping risk and China’s overcapacity are structural headwinds to the Rossari Biotech stock prediction reflected in the cautious Rossari Biotech share price prediction.
Raw Material Cost Volatility
Petrochemical feedstocks see frequent price swings. Sustained input cost increases compress margins and force downward revisions to the Rossari Biotech stock forecast.
Export Demand Weakness
Global industrial demand weakness or inventory destocking by key export customers directly affects volumes and the Rossari Biotech share price prediction.
Regulatory and Environmental Risk
Increasing environmental and safety regulations affect compliance costs and are recurring risks to the Rossari Biotech share price prediction.
How to Monitor the Rossari Biotech Stock Forecast
Track the Rossari Biotech share price prediction consensus quarterly. After every earnings release, most brokerages revise their Rossari Biotech stock forecast within two weeks. Comparing the revised analyst target to the previous estimate tells you whether sentiment on Rossari Biotech is improving or deteriorating.
Compare the current price of Rs 515.35 with the analyst target range of Rs 620 to Rs 580. A wide target band reflects genuine uncertainty on Rossari Biotech, so position size should reflect that range rather than the midpoint alone.
Review the Rossari Biotech share price prediction every quarter against key business metrics for the Specialty Chemicals and Agrochemicals sector. A single estimate from any analyst is a point-in-time view and should be treated as one input among many when making any investment decision.
Check Live Rossari Biotech Fundamentals on the Univest Screener
Conclusion
The Rossari Biotech stock prediction for 2026 reflects the analyst community’s assessment of Rossari Biotech’s competitive position, earnings trajectory and macro environment. JM Financial holds a Neutral stance with a target of Rs 620 while Kotak Securities has a Neutral rating with a target of Rs 580, giving an analyst consensus of Rs 600.
The Rossari Biotech stock forecast is set against near-term risks that make the Rossari Biotech share price prediction range wide. Investors should verify any estimate with the latest brokerage reports before using it as an investment reference. The analyst forecast will be revised after every quarterly result, so tracking how the Rossari Biotech share price target changes over time is more valuable than relying on any single estimate.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.
Download the Univest iOS App or Univest Android App to track live analyst targets, price movements and research updates for Rossari Biotech in real time.
Disclaimer: Data and figures in this article are sourced from publicly available information and may or may not be accurate. Analyst price targets are from public brokerage reports and should be independently verified. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Rossari Biotech Stock Prediction 2026
What is the Rossari Biotech stock prediction for 2026?
Ans. The Rossari Biotech stock prediction for 2026 is based on analyst consensus from JM Financial and Kotak Securities. The consensus target is Rs 600. All estimates may or may not be achieved.
Is the Rossari Biotech stock prediction bullish or bearish?
Ans. JM Financial has a Neutral rating with target Rs 620. Kotak Securities has a Neutral rating with target Rs 580. The Rossari Biotech stock forecast reflects genuine analyst diversity of opinion.
What is the Rossari Biotech share price prediction based on fundamentals?
Ans. The Rossari Biotech share price prediction rests on the export order recovery, margin trajectory, China competition dynamics and capacity utilisation. Analysts tracking Rossari Biotech closely cite these as the primary drivers of the 2026 outlook.
What is the long-term Rossari Biotech stock prediction?
Ans. The long-term outlook assumes Rossari Biotech sustains its core business drivers over a multi-year horizon. The 12-month consensus of Rs 600 is the nearest reliable anchor point.
What are the key risks to the Rossari Biotech stock prediction?
Ans. The primary risks include sector-specific headwinds, macro uncertainty, regulatory changes and competitive pressure. Every analyst estimate for Rossari Biotech should be read alongside its risk assumptions.
What does the Rossari Biotech stock forecast say for 2026?
Ans. JM Financial: Neutral target Rs 620. Kotak Securities: Neutral target Rs 580. These Rossari Biotech share price prediction estimates may or may not prove accurate.
Where can I track the latest Rossari Biotech stock prediction?
Ans. Track the latest analyst targets and price movements for Rossari Biotech on the NSE and BSE websites and on the Univest app and screener for live data.
